RGT.L

Argent BioPharma Limited RGT.L

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RGT.L TCF.L CNSL.L BELL.L DEST.L CLAI.L HELD.L RENE.L KNB.L ONC.L
6M -65.71 % -6.67 % 0.00 % -48.28 % -90.91 % -32.43 % -65.45 % -61.43 % -47.06 % -92.83 %
YTD 0.00 % -60.00 % -3.57 % -91.89 % -95.49 % 56.25 % -73.90 % -3.57 % -75.00 % -91.94 %
1Y -70.73 % -66.40 % -18.18 % -94.00 % -94.64 % 85.19 % -91.52 % -68.75 % -82.00 % -95.48 %
3Y -70.73 % -95.80 % 3.85 % -98.64 % -97.45 % -92.65 % -93.71 % -96.69 % -90.82 % -99.07 %
5Y -70.73 % -98.20 % -97.16 % -98.58 % -92.74 % -99.34 % -93.71 % -95.64 % -95.16 % -98.34 %
10Y -70.73 % -99.32 % -81.15 % -98.58 % -98.62 % -99.34 % -93.71 % -98.93 % -95.50 % -99.14 %
From the beginning -70.73 % -99.39 % -99.99 % -98.58 % -98.62 % -99.34 % -93.71 % -99.84 % -95.50 % -99.14 %

Dividend